Structure

Physi-Chem Properties

Molecular Weight:  406.18
Volume:  426.953
LogP:  5.79
LogD:  3.453
LogS:  -3.898
# Rotatable Bonds:  3
TPSA:  79.9
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.468
Synthetic Accessibility Score:  4.031
Fsp3:  0.32
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.837
MDCK Permeability:  1.1103959877800662e-05
Pgp-inhibitor:  0.786
Pgp-substrate:  0.5
Human Intestinal Absorption (HIA):  0.065
20% Bioavailability (F20%):  0.39
30% Bioavailability (F30%):  0.008

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.009
Plasma Protein Binding (PPB):  86.6405258178711%
Volume Distribution (VD):  0.932
Pgp-substrate:  9.683526992797852%

ADMET: Metabolism

CYP1A2-inhibitor:  0.702
CYP1A2-substrate:  0.67
CYP2C19-inhibitor:  0.82
CYP2C19-substrate:  0.134
CYP2C9-inhibitor:  0.863
CYP2C9-substrate:  0.893
CYP2D6-inhibitor:  0.632
CYP2D6-substrate:  0.32
CYP3A4-inhibitor:  0.299
CYP3A4-substrate:  0.142

ADMET: Excretion

Clearance (CL):  2.004
Half-life (T1/2):  0.067

ADMET: Toxicity

hERG Blockers:  0.012
Human Hepatotoxicity (H-HT):  0.934
Drug-inuced Liver Injury (DILI):  0.934
AMES Toxicity:  0.531
Rat Oral Acute Toxicity:  0.403
Maximum Recommended Daily Dose:  0.812
Skin Sensitization:  0.504
Carcinogencity:  0.841
Eye Corrosion:  0.003
Eye Irritation:  0.214
Respiratory Toxicity:  0.197

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC186113

Natural Product ID:  NPC186113
Common Name*:   Shamixanthone
IUPAC Name:   (1R,2S)-1,11-dihydroxy-5-methyl-8-(3-methylbut-2-enyl)-2-prop-1-en-2-yl-2,3-dihydro-1H-pyrano[3,2-a]xanthen-12-one
Synonyms:   Shamixanthone
Standard InCHIKey:  MXGMZMKTWCNKRS-OPAMFIHVSA-N
Standard InCHI:  InChI=1S/C25H26O5/c1-12(2)6-7-15-8-9-17(26)19-23(28)20-18(30-25(15)19)10-14(5)24-21(20)22(27)16(11-29-24)13(3)4/h6,8-10,16,22,26-27H,3,7,11H2,1-2,4-5H3/t16-,22-/m1/s1
SMILES:  CC(=CCc1ccc(c2c1oc1cc(C)c3c(c1c2=O)[C@H](O)[C@H](CO3)C(=C)C)O)C
Synthetic Gene Cluster:   BGC0000101;
ChEMBL Identifier:   CHEMBL469860
PubChem CID:   15596091
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones
                • [CHEMONTID:0003518] 4-prenylated xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO27885.1 Aspergillus nidulans var. acristatus Varieties Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[16872131]
NPO33058 emericella sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[17323993]
NPO33058 emericella sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[19013822]
NPO27885.1 Aspergillus nidulans var. acristatus Varieties Aspergillaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1621 Individual Protein Calmodulin Homo sapiens IC50 = 29160.0 nM PMID[536128]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC = 50.0 ug.mL-1 PMID[536126]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 50.0 ug.mL-1 PMID[536126]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 50.0 ug.mL-1 PMID[536126]
NPT19 Organism Escherichia coli Escherichia coli MIC = 50.0 ug.mL-1 PMID[536126]
NPT2 Others Unspecified Kd = 28.8 nM PMID[536130]
NPT2 Others Unspecified Ki = 83.0 nM PMID[536130]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC186113 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9804 High Similarity NPC473961
0.9733 High Similarity NPC135522
0.9554 High Similarity NPC225419
0.9434 High Similarity NPC241874
0.9434 High Similarity NPC474004
0.9408 High Similarity NPC474843
0.9333 High Similarity NPC71055
0.929 High Similarity NPC44199
0.9281 High Similarity NPC87708
0.9276 High Similarity NPC202595
0.9276 High Similarity NPC227122
0.9245 High Similarity NPC178173
0.9221 High Similarity NPC95842
0.9221 High Similarity NPC280530
0.9221 High Similarity NPC178964
0.9216 High Similarity NPC72958
0.9216 High Similarity NPC232645
0.9182 High Similarity NPC25361
0.9172 High Similarity NPC471976
0.9156 High Similarity NPC281272
0.915 High Similarity NPC37348
0.9145 High Similarity NPC5537
0.9139 High Similarity NPC469758
0.9119 High Similarity NPC197168
0.9114 High Similarity NPC18380
0.9114 High Similarity NPC3629
0.9085 High Similarity NPC266499
0.9085 High Similarity NPC473016
0.9079 High Similarity NPC308200
0.9073 High Similarity NPC469764
0.9068 High Similarity NPC117854
0.9068 High Similarity NPC6588
0.9068 High Similarity NPC477154
0.9057 High Similarity NPC472402
0.9057 High Similarity NPC15374
0.9051 High Similarity NPC184326
0.9051 High Similarity NPC292863
0.9045 High Similarity NPC281137
0.9045 High Similarity NPC282390
0.9038 High Similarity NPC55662
0.9038 High Similarity NPC166054
0.9032 High Similarity NPC154683
0.9032 High Similarity NPC40356
0.9026 High Similarity NPC29777
0.9026 High Similarity NPC471115
0.9026 High Similarity NPC472633
0.902 High Similarity NPC37135
0.902 High Similarity NPC39195
0.902 High Similarity NPC145467
0.902 High Similarity NPC186397
0.9013 High Similarity NPC290133
0.9013 High Similarity NPC24136
0.9013 High Similarity NPC187282
0.9013 High Similarity NPC472629
0.9006 High Similarity NPC128293
0.9006 High Similarity NPC120593
0.9 High Similarity NPC207690
0.9 High Similarity NPC273959
0.9 High Similarity NPC290160
0.8994 High Similarity NPC474187
0.8994 High Similarity NPC137232
0.8994 High Similarity NPC474186
0.8987 High Similarity NPC195167
0.8987 High Similarity NPC329091
0.8987 High Similarity NPC85121
0.8981 High Similarity NPC164427
0.8974 High Similarity NPC193200
0.8974 High Similarity NPC210942
0.8974 High Similarity NPC329844
0.8974 High Similarity NPC169990
0.897 High Similarity NPC324220
0.897 High Similarity NPC312630
0.8968 High Similarity NPC470675
0.8968 High Similarity NPC46564
0.8968 High Similarity NPC39819
0.8968 High Similarity NPC207346
0.8968 High Similarity NPC149526
0.8968 High Similarity NPC478148
0.8968 High Similarity NPC470569
0.8968 High Similarity NPC473131
0.8968 High Similarity NPC474417
0.8963 High Similarity NPC154986
0.8961 High Similarity NPC97029
0.8961 High Similarity NPC223988
0.8961 High Similarity NPC288036
0.8961 High Similarity NPC65589
0.8961 High Similarity NPC471114
0.8961 High Similarity NPC158338
0.8961 High Similarity NPC100985
0.8961 High Similarity NPC97028
0.8951 High Similarity NPC474024
0.8947 High Similarity NPC87486
0.8947 High Similarity NPC311144
0.8947 High Similarity NPC124780
0.8947 High Similarity NPC470890
0.8947 High Similarity NPC271288
0.8938 High Similarity NPC229632
0.8931 High Similarity NPC474287
0.8931 High Similarity NPC470810
0.8931 High Similarity NPC119224
0.8931 High Similarity NPC475886
0.8931 High Similarity NPC321399
0.8931 High Similarity NPC472618
0.8924 High Similarity NPC165977
0.8924 High Similarity NPC196448
0.8924 High Similarity NPC272196
0.8924 High Similarity NPC217677
0.8924 High Similarity NPC475184
0.8917 High Similarity NPC175192
0.891 High Similarity NPC273483
0.891 High Similarity NPC475790
0.8903 High Similarity NPC290954
0.8903 High Similarity NPC294646
0.8903 High Similarity NPC470568
0.8903 High Similarity NPC255641
0.8903 High Similarity NPC147735
0.8903 High Similarity NPC101957
0.8903 High Similarity NPC120105
0.8896 High Similarity NPC7025
0.8896 High Similarity NPC106328
0.8896 High Similarity NPC27221
0.8896 High Similarity NPC256672
0.8896 High Similarity NPC35150
0.8889 High Similarity NPC43319
0.8889 High Similarity NPC470676
0.8889 High Similarity NPC272502
0.8889 High Similarity NPC299011
0.8889 High Similarity NPC473132
0.8889 High Similarity NPC37870
0.8889 High Similarity NPC473135
0.8889 High Similarity NPC251336
0.8882 High Similarity NPC77794
0.8882 High Similarity NPC85162
0.8882 High Similarity NPC125894
0.8882 High Similarity NPC223812
0.8882 High Similarity NPC152659
0.8882 High Similarity NPC278249
0.8882 High Similarity NPC248638
0.8882 High Similarity NPC81697
0.8882 High Similarity NPC7483
0.8882 High Similarity NPC113770
0.8882 High Similarity NPC107177
0.8882 High Similarity NPC236521
0.8882 High Similarity NPC236132
0.8875 High Similarity NPC66288
0.8875 High Similarity NPC475883
0.8875 High Similarity NPC32694
0.8875 High Similarity NPC474351
0.8868 High Similarity NPC210459
0.8868 High Similarity NPC226287
0.8868 High Similarity NPC324736
0.8868 High Similarity NPC472617
0.8868 High Similarity NPC51760
0.8861 High Similarity NPC69531
0.8861 High Similarity NPC78492
0.8861 High Similarity NPC208152
0.8861 High Similarity NPC142339
0.8855 High Similarity NPC475246
0.8854 High Similarity NPC477691
0.8846 High Similarity NPC312549
0.8846 High Similarity NPC474023
0.8846 High Similarity NPC209142
0.8846 High Similarity NPC178484
0.8846 High Similarity NPC474021
0.8841 High Similarity NPC477572
0.8841 High Similarity NPC477573
0.8841 High Similarity NPC477571
0.8841 High Similarity NPC251144
0.8841 High Similarity NPC103307
0.8841 High Similarity NPC241387
0.8839 High Similarity NPC70764
0.8839 High Similarity NPC65775
0.8839 High Similarity NPC329933
0.8839 High Similarity NPC10027
0.8839 High Similarity NPC5173
0.8834 High Similarity NPC218226
0.8831 High Similarity NPC473077
0.8831 High Similarity NPC300988
0.8831 High Similarity NPC296998
0.8831 High Similarity NPC7943
0.8831 High Similarity NPC22005
0.8831 High Similarity NPC10990
0.8831 High Similarity NPC123202
0.8827 High Similarity NPC473286
0.8827 High Similarity NPC239752
0.8827 High Similarity NPC472450
0.8827 High Similarity NPC326520
0.8827 High Similarity NPC275780
0.8827 High Similarity NPC469664
0.8827 High Similarity NPC293319
0.8824 High Similarity NPC473015
0.8824 High Similarity NPC131568
0.8824 High Similarity NPC224714
0.8824 High Similarity NPC184649
0.8824 High Similarity NPC131579
0.8824 High Similarity NPC473013
0.8824 High Similarity NPC303185
0.8824 High Similarity NPC235217
0.8824 High Similarity NPC473014
0.882 High Similarity NPC329760

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC186113 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8994 High Similarity NPD6959 Discontinued
0.8734 High Similarity NPD2393 Clinical (unspecified phase)
0.8696 High Similarity NPD5494 Approved
0.8679 High Similarity NPD8443 Clinical (unspecified phase)
0.8616 High Similarity NPD7819 Suspended
0.8581 High Similarity NPD4378 Clinical (unspecified phase)
0.8554 High Similarity NPD5844 Phase 1
0.8544 High Similarity NPD4380 Phase 2
0.8487 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8487 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8438 Intermediate Similarity NPD1934 Approved
0.8431 Intermediate Similarity NPD1549 Phase 2
0.8385 Intermediate Similarity NPD2801 Approved
0.8373 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8373 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8373 Intermediate Similarity NPD6166 Phase 2
0.8344 Intermediate Similarity NPD2533 Approved
0.8344 Intermediate Similarity NPD2532 Approved
0.8344 Intermediate Similarity NPD2534 Approved
0.8323 Intermediate Similarity NPD7473 Discontinued
0.8294 Intermediate Similarity NPD6559 Discontinued
0.8261 Intermediate Similarity NPD7411 Suspended
0.8253 Intermediate Similarity NPD6232 Discontinued
0.8247 Intermediate Similarity NPD2346 Discontinued
0.8232 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8232 Intermediate Similarity NPD7075 Discontinued
0.8228 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8225 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8221 Intermediate Similarity NPD5402 Approved
0.8205 Intermediate Similarity NPD3750 Approved
0.8198 Intermediate Similarity NPD8312 Approved
0.8198 Intermediate Similarity NPD8313 Approved
0.8182 Intermediate Similarity NPD2796 Approved
0.8182 Intermediate Similarity NPD2935 Discontinued
0.8176 Intermediate Similarity NPD7074 Phase 3
0.8171 Intermediate Similarity NPD7768 Phase 2
0.816 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD3226 Approved
0.8118 Intermediate Similarity NPD7054 Approved
0.8117 Intermediate Similarity NPD1510 Phase 2
0.8105 Intermediate Similarity NPD1607 Approved
0.8079 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8077 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.807 Intermediate Similarity NPD7472 Approved
0.805 Intermediate Similarity NPD1511 Approved
0.8047 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8035 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8023 Intermediate Similarity NPD6797 Phase 2
0.8012 Intermediate Similarity NPD3749 Approved
0.8 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD6801 Discontinued
0.7977 Intermediate Similarity NPD7251 Discontinued
0.7974 Intermediate Similarity NPD1240 Approved
0.7961 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7953 Intermediate Similarity NPD3818 Discontinued
0.7952 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD3882 Suspended
0.795 Intermediate Similarity NPD1512 Approved
0.7949 Intermediate Similarity NPD6099 Approved
0.7949 Intermediate Similarity NPD6100 Approved
0.7949 Intermediate Similarity NPD1551 Phase 2
0.7937 Intermediate Similarity NPD7390 Discontinued
0.7931 Intermediate Similarity NPD7808 Phase 3
0.7911 Intermediate Similarity NPD2800 Approved
0.7895 Intermediate Similarity NPD4625 Phase 3
0.7885 Intermediate Similarity NPD3748 Approved
0.7885 Intermediate Similarity NPD2799 Discontinued
0.7866 Intermediate Similarity NPD6599 Discontinued
0.7862 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD4908 Phase 1
0.7824 Intermediate Similarity NPD5711 Approved
0.7824 Intermediate Similarity NPD5710 Approved
0.7791 Intermediate Similarity NPD5403 Approved
0.7784 Intermediate Similarity NPD3817 Phase 2
0.7778 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7772 Intermediate Similarity NPD6777 Approved
0.7772 Intermediate Similarity NPD6776 Approved
0.7772 Intermediate Similarity NPD6779 Approved
0.7772 Intermediate Similarity NPD6778 Approved
0.7772 Intermediate Similarity NPD6781 Approved
0.7772 Intermediate Similarity NPD6782 Approved
0.7772 Intermediate Similarity NPD6780 Approved
0.7765 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD7697 Approved
0.7742 Intermediate Similarity NPD7696 Phase 3
0.7742 Intermediate Similarity NPD7698 Approved
0.7727 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7725 Intermediate Similarity NPD1465 Phase 2
0.7716 Intermediate Similarity NPD6799 Approved
0.7714 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD4363 Phase 3
0.7692 Intermediate Similarity NPD4360 Phase 2
0.7688 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD6823 Phase 2
0.7669 Intermediate Similarity NPD5401 Approved
0.7665 Intermediate Similarity NPD6844 Discontinued
0.7665 Intermediate Similarity NPD37 Approved
0.7654 Intermediate Similarity NPD8150 Discontinued
0.7647 Intermediate Similarity NPD2861 Phase 2
0.7647 Intermediate Similarity NPD7435 Discontinued
0.7644 Intermediate Similarity NPD7783 Phase 2
0.7644 Intermediate Similarity NPD7228 Approved
0.7644 Intermediate Similarity NPD3751 Discontinued
0.7644 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD4628 Phase 3
0.7633 Intermediate Similarity NPD4966 Approved
0.7633 Intermediate Similarity NPD4965 Approved
0.7633 Intermediate Similarity NPD4967 Phase 2
0.7622 Intermediate Similarity NPD6273 Approved
0.7616 Intermediate Similarity NPD3787 Discontinued
0.7613 Intermediate Similarity NPD2313 Discontinued
0.7613 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD5406 Approved
0.761 Intermediate Similarity NPD5408 Approved
0.761 Intermediate Similarity NPD5405 Approved
0.761 Intermediate Similarity NPD5404 Approved
0.7606 Intermediate Similarity NPD7870 Phase 2
0.7606 Intermediate Similarity NPD7871 Phase 2
0.7605 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD1610 Phase 2
0.758 Intermediate Similarity NPD5124 Phase 1
0.758 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7579 Intermediate Similarity NPD7701 Phase 2
0.7578 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD920 Approved
0.7561 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD1247 Approved
0.7544 Intermediate Similarity NPD6234 Discontinued
0.7539 Intermediate Similarity NPD8151 Discontinued
0.7532 Intermediate Similarity NPD6651 Approved
0.7531 Intermediate Similarity NPD7003 Approved
0.7516 Intermediate Similarity NPD1613 Approved
0.7516 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD1470 Approved
0.7514 Intermediate Similarity NPD7229 Phase 3
0.7514 Intermediate Similarity NPD5953 Discontinued
0.75 Intermediate Similarity NPD4749 Approved
0.75 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6535 Approved
0.75 Intermediate Similarity NPD6534 Approved
0.75 Intermediate Similarity NPD7286 Phase 2
0.7483 Intermediate Similarity NPD1201 Approved
0.7483 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD7700 Phase 2
0.7473 Intermediate Similarity NPD7699 Phase 2
0.7461 Intermediate Similarity NPD7801 Approved
0.7455 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD2344 Approved
0.7409 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7409 Intermediate Similarity NPD7874 Approved
0.7394 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7363 Intermediate Similarity NPD8434 Phase 2
0.7362 Intermediate Similarity NPD1243 Approved
0.7355 Intermediate Similarity NPD2798 Approved
0.7338 Intermediate Similarity NPD1283 Approved
0.7333 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD5761 Phase 2
0.731 Intermediate Similarity NPD8455 Phase 2
0.731 Intermediate Similarity NPD5760 Phase 2
0.7308 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD4060 Phase 1
0.7296 Intermediate Similarity NPD2979 Phase 3
0.7296 Intermediate Similarity NPD943 Approved
0.729 Intermediate Similarity NPD1203 Approved
0.729 Intermediate Similarity NPD2797 Approved
0.7285 Intermediate Similarity NPD1651 Approved
0.7278 Intermediate Similarity NPD3268 Approved
0.7278 Intermediate Similarity NPD7458 Discontinued
0.7278 Intermediate Similarity NPD7240 Approved
0.7273 Intermediate Similarity NPD4361 Phase 2
0.7273 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD3926 Phase 2
0.7273 Intermediate Similarity NPD2309 Approved
0.7267 Intermediate Similarity NPD4288 Approved
0.7261 Intermediate Similarity NPD6832 Phase 2
0.7261 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7258 Intermediate Similarity NPD6213 Phase 3
0.7258 Intermediate Similarity NPD6212 Phase 3
0.7258 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD7199 Phase 2
0.725 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7247 Intermediate Similarity NPD7177 Discontinued
0.7244 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD919 Approved
0.724 Intermediate Similarity NPD8320 Phase 1
0.724 Intermediate Similarity NPD8319 Approved
0.7239 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD7033 Discontinued
0.7222 Intermediate Similarity NPD4308 Phase 3
0.7219 Intermediate Similarity NPD1548 Phase 1
0.7215 Intermediate Similarity NPD3027 Phase 3
0.7197 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD2424 Discontinued
0.7178 Intermediate Similarity NPD2438 Suspended
0.717 Intermediate Similarity NPD3764 Approved
0.717 Intermediate Similarity NPD411 Approved
0.7152 Intermediate Similarity NPD6674 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data